Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells.

BMC Cancer
Ji-Young JangChul-Woo Kim

Abstract

In breast cancer, the HER2/neu oncoprotein, which belongs to the epidermal growth factor receptor family, may trigger activation of the phosphoinositide-3 kinase (PI3K)/Akt pathway, which controls cell proliferation, survival, migration, and invasion. In this study, we examined the question of whether or not adenine nucleotide translocase 2 (ANT2) short hairpin RNA (shRNA)-mediated down-regulation of HER2/neu and inhibitory effects on the PI3K/Akt signaling pathway suppressed migration and invasiveness of breast cancer cells. We utilized an ANT2 vector-based RNA interference approach to inhibition of ANT2 expression, and the HER2/neu-overexpressing human breast cancer cell line, SK-BR3, was used throughout the study. In this study, ANT2 shRNA decreased HER2/neu protein levels by promoting degradation of HER2/neu protein through dissociation from heat shock protein 90 (HSP90). As a result, ANT2 shRNA induced inhibitory effects on the PI3K/Akt signaling pathway. Inhibition of PI3K/Akt signaling by ANT2 shRNA caused down-regulation of membrane-type 1 matrix metalloproteinase (MT1-MMP) and vascular endothelial growth factor (VEGF) expression, decreased matrix metalloproteinase 2 (MMP2) and MMP9 activity, and suppressed migration an...Continue Reading

References

Mar 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BaselgaL Norton
Nov 17, 1998·The Journal of Cell Biology·W M ObermannF U Hartl
Jan 7, 2000·Journal of Cellular Physiology·S MénardS M Pupa
Mar 14, 2000·The Journal of Biological Chemistry·B P ZhouM C Hung
Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
Apr 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·J FangM A Moses
Jul 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S M BaidasD F Hayes
May 9, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C VogelS J. Stewart
Oct 2, 2001·CA: a Cancer Journal for Clinicians·R T GreenleeM Thun
Nov 1, 2001·Annual Review of Cell and Developmental Biology·M D Sternlicht, Z Werb
Feb 28, 2002·The Journal of Biological Chemistry·Anil Kumar BhuniaSubroto Chatterjee
Jul 16, 2002·The Journal of Biological Chemistry·Carmen García-RuizJosé C Fernández-Checa
Jul 2, 2003·Nature Reviews. Cancer·Jasti S Rao
Apr 9, 2004·FEBS Letters·Amere Subbarao SreedharYu-Fei Shen
Oct 21, 2005·The New England Journal of Medicine·Martine J Piccart-GebhartUNKNOWN Herceptin Adjuvant (HERA) Trial Study Team
Oct 21, 2005·The New England Journal of Medicine·Edward H RomondNorman Wolmark
Dec 13, 2005·Journal of Bioenergetics and Biomembranes·Arnaud ChevrollierGeorges Stepien
Sep 20, 2006·Cancer Research·Morgane Le BrasCatherine Brenner
Sep 27, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maurizio Scaltriti, José Baselga
Oct 6, 2006·Nature Structural & Molecular Biology·Peter C StirlingMichel R Leroux
Dec 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mayumi Ono, Michihiko Kuwano
Jan 27, 2009·Cancer Metastasis Reviews·Mahmut Yilmaz, Gerhard Christofori

❮ Previous
Next ❯

Citations

Dec 22, 2012·Future Medicinal Chemistry·Shijun WenPeng Huang
May 26, 2011·Biochemical and Biophysical Research Communications·Xiu-Li LiuYan Li
Sep 7, 2013·International Journal of Oncology·Soyoung KimKyung-Soo Nam
Sep 19, 2019·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Wenxia WangXiaoli Lan
Aug 27, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Peyman RanjiAli Mohammad Alizadeh
May 26, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jin Ho PaikChul-Woo Kim

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
electrophoresis
flow cytometry

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Advanced Imaging of Cellular Signaling

Cell signaling is a vital mechanism for communication within cells and outside with the environment. Several different signaling pathways have been found and advanced imaging techniques are being developed to visualize the molecules involved in these signaling pathways. Find the latest research in advanced imaging of cellular signaling here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.